logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
Showing 1 - 15 of 15 Items
Showing 1 - 15 of 15 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Yield of TB screening in prisons in Tajikistan

Moe S, Asozoda M, Aung A, Dusmatova Z, Akintore F,  et al.
2024-08-01 • IJTLD OPEN
2024-08-01 • IJTLD OPEN

BACKGROUND

The rate of TB in prison institutions is estimated to be 23 times higher than in the general population. Limited documentation exists regarding TB screening in Tajiki...

Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Letter
Journal Article
|
Research
Conference Material
|
Abstract
Conference Material
|
Poster
Conference Material
|
Video

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Conference Material
|
Slide Presentation
Journal Article
|
Research
Journal Article
|
Commentary

Household drug-resistant TB contact tracing in Tajikistan

Rekart ML, Aung A, Cullip T, Mulanda WK, Mun L,  et al.
2023-10-01 • International Journal of Tuberculosis and Lung Disease
2023-10-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
Tajikistan has a high burden of rifampicin-resistant TB (RR-TB), with 2,700 new cases estimated for 2021 (28/100,000 population). TB is spread among household members thro...

Detection of Mycobacterium tuberculosis complex using the Xpert MTB/RIF Ultra assay on the stool of pediatric patients in Dushanbe, Tajikistan

Rekart ML, Mun L, Aung A, Gomez D, Mulanda WK,  et al.
2023-01-09 • Microbiology Spectrum
2023-01-09 • Microbiology Spectrum
We report the findings of a prospective laboratory diagnostic accuracy study to evaluate the sensitivity, specificity, and predictive values of the Xpert MTB/RIF Ultra assay for Mycobact...

Family directly observed therapy for children with drug-resistant TB

Rekart ML, Morshed T, Mulanda WK, Klieascikova J, Sitali N,  et al.
2022-08-01 • International Journal of Tuberculosis and Lung Disease
2022-08-01 • International Journal of Tuberculosis and Lung Disease

Peripheral Neuropathy in a Diabetic Child Treated with Linezolid for Multidrug-Resistant Tuberculosis: A Case Report and Review of the Literature

Swaminathan A, du Cros PAK, Seddon JA, Mirgayosieva S, Asladdin R,  et al.
2017-06-12 • BMC Infectious Diseases
2017-06-12 • BMC Infectious Diseases
Extensively drug-resistant (XDR) tuberculosis (TB) and multidrug resistant (MDR)-TB with additional resistance to injectable agents or fluoroquinolones are challenging to treat due to la...

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA, Puig-García M, Silver C, Pearlman J, Stellmach DUS,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
Between 2020 and 2021, MSF’s social sciences team designed and supported implementation of qualitative assessments to better understand community-level outbreak response...

Detection of Mycobacterium tuberculosis complex in the stool of pediatric patients using the Xpert MTB/Rif Ultra assay

Mun L, Gomez D, Sitali N, Rajabzoda A, Azamova S,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022

Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central Asia

du Cros PAK, Swaminathan A, Bobokhojaev O, Sharifovna ZD, Martin C,  et al.
2015-06-21 • Public Health Action
2015-06-21 • Public Health Action
Guidelines for children with drug-resistant tuberculosis (DR-TB) tend to focus on individual patient care; there is little guidance for national tuberculosis programmes (NTPs) on how to...

Detecting tuberculosis: rapid tools but slow progress

England K, Masini T, Fajardo E
2019-09-21 • Public Health Action
2019-09-21 • Public Health Action
The World Health Organization (WHO) currently recommends Xpert® MTB/RIF as the initial test for all people with presumptive tuberculosis (TB). A number of challenges have been reported, ...

Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications

Swaminathan A, du Cros PAK, Seddon JA, Quinnell S, Bobokhojaev O,  et al.
2016-04-01 • International Journal of Tuberculosis and Lung Disease
2016-04-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
Management of extensively drug-resistant tuberculosis (XDR-TB) and pre-XDR-TB is challenging, as effective drugs are lacking. Group 5 anti-tuberculosis drugs have an uncle...

Off-label use of bedaquiline in children and adolescents with multidrug-resistant tuberculosis

Achar J, Hewison CCH, Cavalheiro AP, Skrahina A, Cajazeiro J,  et al.
2017-10-01 • Emerging Infectious Diseases
2017-10-01 • Emerging Infectious Diseases
We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessati...

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA, Puig-García M, Silver C, Pearlman J, Stellmach DUS,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

Cox V, Brigden G, Crespo RH, Lessem E, Lynch S,  et al.
2018-04-01 • International Journal of Tuberculosis and Lung Disease
2018-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING
The World Health Organization recommended two new drugs, bedaquiline (BDQ) and delamanid (DLM), for the treatment of multidrug-resistant tuberculosis (MDR-TB) in 2013 and 201...

Public health advocacy for the Berlin Declaration on tuberculosis in the former Soviet Union: the view of Médecins Sans Frontières

Healy S, Dietrich S, Roth T, Nyang'wa BT, du Cros PAK
2012-12-11 • European Journal of Microbiology and Immunology
2012-12-11 • European Journal of Microbiology and Immunology